Sign In
Buy DCTH
$10.33
-0.200 (-1.90%)
At Close: Jun 03, 2026
Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging
12:00pm, Monday, 22'nd Jul 2019
Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that results from a single-institution retrospective
Biotech Stock Forecast: 2019 Remains Bullish for These 3 Healthcare Stocks
12:33pm, Thursday, 22'nd Nov 2018
A volatile biotech sector sent the share prices of many of the best healthcare stocks reeling. Thanks to gridlock in Washington, concerns that President Donald Trump will get rid of Obamacare and cut
